Technology
Analog Devices Reports Fourth Quarter and Fiscal 2024 Financial Results
Published
2 years agoon
By
Fourth quarter revenue of more than $2.4 billion, above the midpoint of guidance with sequential growth across all end marketsFiscal 2024 revenue of more than $9.4 billionFiscal 2024 operating cash flow of $3.9 billion and free cash flow of $3.1 billionReturned more than $2.4 billion to shareholders in fiscal 2024, including $0.6 billion of share repurchases and $1.8 billion of dividends
WILMINGTON, Mass., Nov. 26, 2024 /PRNewswire/ — Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, today announced financial results for its fiscal fourth quarter and fiscal year 2024, which ended November 2, 2024.
“ADI’s revenue, profitability, and earnings per share all finished above our guided midpoint, underscoring continued business momentum and solid execution,” said Vincent Roche, CEO and Chair. “While unprecedented customer inventory headwinds drove a historic revenue decline during fiscal 2024, we maintained operating margins north of 40%, which is a testament to our business model’s resilience. We also continued to make strategic, long-term investments across engineering, manufacturing, and the end-to-end customer experience. As such, we enter 2025 as an even stronger enterprise, giving me the utmost confidence in our ability to drive increased value for customers and shareholders over the long term.”
“After a brief decline in overall bookings during our third quarter, orders picked up steadily throughout the fourth quarter, particularly in the Automotive end market. While macro uncertainty continues to limit the pace of our recovery, we remain cautiously optimistic for a strong growth year in fiscal 2025,” said Richard Puccio, CFO.
Performance for the Fourth Quarter and Fiscal Year 2024
Results Summary(1)
(in millions, except per-share amounts and percentages)
Three Months Ended
Twelve Months Ended
Nov. 2,
2024
Oct. 28,
2023
Change
Nov. 2,
2024
Oct. 28,
2023
Change
Revenue
$ 2,443
$ 2,716
(10) %
$ 9,427
$ 12,306
(23) %
Gross margin
$ 1,416
$ 1,647
(14) %
$ 5,381
$ 7,877
(32) %
Gross margin percentage
58.0 %
60.6 %
(260 bps)
57.1 %
64.0 %
(690 bps)
Operating income
$ 569
$ 634
(10) %
$ 2,033
$ 3,823
(47) %
Operating margin
23.3 %
23.4 %
(10 bps)
21.6 %
31.1 %
(950 bps)
Diluted earnings per share
$ 0.96
$ 1.00
(4) %
$ 3.28
$ 6.55
(50) %
Adjusted Results(2)
Adjusted gross margin
$ 1,660
$ 1,907
(13) %
$ 6,404
$ 8,925
(28) %
Adjusted gross margin percentage
67.9 %
70.2 %
(230 bps)
67.9 %
72.5 %
(460 bps)
Adjusted operating income
$ 1,005
$ 1,215
(17) %
$ 3,853
$ 6,014
(36) %
Adjusted operating margin
41.1 %
44.7 %
(360 bps)
40.9 %
48.9 %
(800 bps)
Adjusted diluted earnings per share
$ 1.67
$ 2.01
(17) %
$ 6.38
$ 10.09
(37) %
Three Months Ended
Trailing Twelve
Months
Cash Generation
Nov. 2, 2024
Nov. 2, 2024
Net cash provided by operating activities
$ 1,051
$ 3,853
% of revenue
43 %
41 %
Capital expenditures
$ (165)
$ (730)
Free cash flow(2)
$ 885
$ 3,122
% of revenue
36 %
33 %
Three Months Ended
Trailing Twelve
Months
Cash Return
Nov. 2, 2024
Nov. 2, 2024
Dividend paid
$ (457)
$ (1,795)
Stock repurchases
(95)
(616)
Total cash returned
$ (552)
$ (2,411)
(1) The sum and/or computation of the individual amounts may not equal the total due to rounding.
(2) Reconciliations of non-GAAP financial measures to their most directly comparable GAAP financial measures are provided in the financial tables included in this press release. See also the “Non-GAAP Financial Information” section for additional information.
Outlook for the First Quarter of Fiscal Year 2025
For the first quarter of fiscal 2025, we are forecasting revenue of $2.35 billion, +/- $100 million. At the midpoint of this revenue outlook, we expect reported operating margin of approximately 22.0%, +/- 130 bps, and adjusted operating margin of approximately 40.0%, +/- 100 bps. We are planning for reported EPS to be $0.80, +/- $0.10, and adjusted EPS to be $1.53, +/- $0.10.
Our first quarter fiscal 2025 outlook is based on current expectations and actual results may differ materially as a result of, among other things, the important factors discussed at the end of this release. These statements supersede all prior statements regarding our business outlook set forth in prior ADI news releases, and ADI disclaims any obligation to update these forward-looking statements.
The adjusted results and adjusted anticipated results above are financial measures presented on a non-GAAP basis. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided in the financial tables included in this release. See also the “Non-GAAP Financial Information” section for additional information.
Dividend Payment
The ADI Board of Directors has declared a quarterly cash dividend of $0.92 per outstanding share of common stock. The dividend will be paid on December 20, 2024 to all shareholders of record at the close of business on December 9, 2024.
Conference Call Scheduled for Today, Tuesday, November 26, 2024 at 10:00 am ET
ADI will host a conference call to discuss our fourth quarter and fiscal 2024 results and short-term outlook today, beginning at 10:00 am ET. Investors may join via webcast, accessible at investor.analog.com.
Non-GAAP Financial Information
This release includes non-GAAP financial measures that are not in accordance with, nor an alternative to, U.S. generally accepted accounting principles (GAAP) and may be different from non-GAAP measures presented by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. These non-GAAP measures have material limitations in that they do not reflect all of the amounts associated with the Company’s results of operations as determined in accordance with GAAP and should not be considered in isolation from, or as a substitute for, the Company’s financial results presented in accordance with GAAP. The Company’s use of non-GAAP measures, and the underlying methodology when including or excluding certain items, is not necessarily an indication of the results of operations that may be expected in the future, or that the Company will not, in fact, record such items in future periods. You are cautioned not to place undue reliance on these non-GAAP measures. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided in the financial tables included in this release.
Management uses non-GAAP measures internally to evaluate the Company’s operating performance from continuing operations against past periods and to budget and allocate resources in future periods. These non-GAAP measures also assist management in evaluating the Company’s core business and trends across different reporting periods on a consistent basis. Management also uses these non-GAAP measures as primary performance measurements when communicating with analysts and investors regarding the Company’s earnings results and outlook and believes that the presentation of these non-GAAP measures is useful to investors because it provides investors with the operating results that management uses to manage the Company and enables investors and analysts to evaluate the Company’s core business. Management also believes that free cash flow, a non-GAAP liquidity measure, is useful both internally and to investors because it provides information about the amount of cash generated after capital expenditures that is then available to repay debt obligations, make investments and fund acquisitions, and for certain other activities.
The non-GAAP financial measures referenced by ADI in this release include: adjusted gross margin, adjusted gross margin percentage, adjusted operating expenses, adjusted operating expenses percentage, adjusted operating income, adjusted operating margin, adjusted nonoperating expense (income), adjusted income before income taxes, adjusted provision for income taxes, adjusted tax rate, adjusted diluted earnings per share (EPS), free cash flow, and free cash flow revenue percentage.
Adjusted gross margin is defined as gross margin, determined in accordance with GAAP, excluding: certain acquisition related expenses1, which are described further below. Adjusted gross margin percentage represents adjusted gross margin divided by revenue.
Adjusted operating expenses is defined as operating expenses, determined in accordance with GAAP, excluding: certain acquisition related expenses1, acquisition related transaction costs2, and special charges, net3, which are described further below. Adjusted operating expenses percentage represents adjusted operating expenses divided by revenue.
Adjusted operating income is defined as operating income, determined in accordance with GAAP, excluding: acquisition related expenses1, acquisition related transaction costs2, and special charges, net3, which are described further below. Adjusted operating margin represents adjusted operating income divided by revenue.
Adjusted nonoperating expense (income) is defined as nonoperating expense (income), determined in accordance with GAAP, excluding: certain acquisition related expenses1, which is described further below.
Adjusted income before income taxes is defined as income before income taxes, determined in accordance with GAAP, excluding: acquisition related expenses1, acquisition related transaction costs2, and special charges, net3, which are described further below.
Adjusted provision for income taxes is defined as provision for income taxes, determined in accordance with GAAP, excluding tax related items4, which are described further below. Adjusted tax rate represents adjusted provision for income taxes divided by adjusted income before income taxes.
Adjusted diluted EPS is defined as diluted EPS, determined in accordance with GAAP, excluding: acquisition related expenses1, acquisition related transaction costs2, special charges, net3, and tax related items4, which are described further below.
Free cash flow is defined as net cash provided by operating activities, determined in accordance with GAAP, less additions to property, plant and equipment, net. Free cash flow revenue percentage represents free cash flow divided by revenue.
1Acquisition Related Expenses: Expenses incurred as a result of current and prior period acquisitions and primarily include expenses associated with the fair value adjustments to debt, inventory, property, plant and equipment and amortization of acquisition related intangibles, which include acquired intangibles such as purchased technology and customer relationships. Expenses also include fair value adjustments associated with the replacement of share-based awards related to the Maxim Integrated Products, Inc. (Maxim) acquisition. We excluded these costs from our non-GAAP measures because they relate to specific transactions and are not reflective of our ongoing financial performance.
2Acquisition Related Transaction Costs: Costs directly related to the Maxim acquisition, including legal, accounting and other professional fees as well as integration-related costs. We excluded these costs from our non-GAAP measures because they relate to a specific transaction and are not reflective of our ongoing financial performance.
3Special Charges, net: Expenses, net, incurred as part of the integration of Maxim, in connection with facility closures, consolidation of manufacturing facilities, severance, other accelerated stock-based compensation expense and other cost reduction efforts or reorganizational initiatives. We excluded these expenses from our non-GAAP measures because apart from ongoing expense savings as a result of such items, these expenses have no direct correlation to the operation of our business in the future.
4Tax Related Items: Income tax effect of the non-GAAP items discussed above, an income tax benefit from a discrete tax item related to a federal corporate income tax relief claim and certain other income tax benefits associated with prior periods. We excluded the income tax effect of these tax related items from our non-GAAP measures because they are not associated with the tax expense on our current operating results.
About Analog Devices, Inc.
Analog Devices, Inc. (NASDAQ: ADI) is a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. ADI combines analog, digital, and software technologies into solutions that help drive advancements in digitized factories, mobility, and digital healthcare, combat climate change, and reliably connect humans and the world. With revenue of more than $9 billion in FY24 and approximately 24,000 people globally, ADI ensures today’s innovators stay Ahead of What’s Possible. Learn more at www.analog.com and on LinkedIn and Twitter (X).
Forward Looking Statements
This press release contains forward-looking statements, which address a variety of subjects including, for example, our statements regarding our 2025 financial performance; expected revenue, operating margin, nonoperating expenses, tax rate, earnings per share, free cash flow returns, and other financial results; customer inventory rationalization; economic uncertainty, geopolitical conditions, demand, and other market conditions, business cycles, and supply chains; capital expenditures and investments, including those related to digital, software, cybersecurity, and artificial intelligence; expected market and technology trends; market size, market share gains, market position, and growth opportunities; our opportunity pipeline; expected product solutions, offerings, technologies, capabilities, and applications, including those that may incorporate, or be based upon, software or artificial intelligence technology; the value and importance of, and other benefits related to, our product solutions, offerings, and technologies to our customers, including those that may incorporate, or be based upon, software or artificial intelligence technology; our manufacturing capacity and investments to enhance resiliency; expected tax credits; future dividends and share repurchases; expected revenue synergies; and other future events. Statements that are not historical facts, including statements about our beliefs, plans and expectations, are forward-looking statements. Such statements are based on our current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: economic, political, legal and regulatory uncertainty or conflicts; changes in demand for semiconductor products; manufacturing delays, product and raw materials availability and supply chain disruptions; products that may be diverted from our authorized distribution channels; changes in export classifications, import and export regulations or duties and tariffs; our development of technologies and research and development investments; our future liquidity, capital needs and capital expenditures; our ability to compete successfully in the markets in which we operate; our ability to recruit and retain key personnel; risks related to acquisitions or other strategic transactions; security breaches or other cyber incidents; risks related to the use of artificial intelligence in our business operations, products, and services; adverse results in litigation matters; reputational damage; changes in our estimates of our expected tax rates based on current tax law; risks related to our indebtedness; the discretion of our Board of Directors to declare dividends and our ability to pay dividends in the future; factors impacting our ability to repurchase shares; and uncertainty as to the long-term value of our common stock. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to our filings with the Securities and Exchange Commission, including the risk factors contained in our most recent Annual Report on Form 10-K. Forward-looking statements represent management’s current expectations and are inherently uncertain. Except as required by law, we do not undertake any obligation to update forward-looking statements made by us to reflect subsequent events or circumstances.
Analog Devices and the Analog Devices logo are registered trademarks or trademarks of Analog Devices, Inc. All other trademarks mentioned in this document are the property of their respective owners.
ANALOG DEVICES, INC.
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except per share amounts)
Three Months Ended
Twelve Months Ended
Nov. 2, 2024
Oct. 28, 2023
Nov. 2, 2024
Oct. 28, 2023
Revenue
$ 2,443,205
$ 2,716,484
$ 9,427,157
$ 12,305,539
Cost of sales
1,027,077
1,069,768
4,045,814
4,428,321
Gross margin
1,416,128
1,646,716
5,381,343
7,877,218
Operating expenses:
Research and development
378,903
406,594
1,487,863
1,660,194
Selling, marketing, general and administrative
277,220
288,936
1,068,640
1,273,584
Amortization of intangibles
187,754
202,736
754,784
959,618
Special charges, net
2,859
114,035
37,258
160,710
Total operating expenses
846,736
1,012,301
3,348,545
4,054,106
Operating income
569,392
634,415
2,032,798
3,823,112
Nonoperating expense (income):
Interest expense
82,804
71,590
322,227
264,641
Interest income
(27,947)
(9,089)
(78,817)
(41,287)
Other, net
(1,793)
128
12,048
(8,245)
Total nonoperating expense (income)
53,064
62,629
255,458
215,109
Income before income taxes
516,328
571,786
1,777,340
3,608,003
Provision for income taxes
38,256
73,356
142,067
293,424
Net income
$ 478,072
$ 498,430
$ 1,635,273
$ 3,314,579
Shares used to compute earnings per share – basic
496,432
497,073
496,166
502,232
Shares used to compute earnings per share – diluted
498,722
500,424
498,697
505,959
Basic earnings per common share
$ 0.96
$ 1.00
$ 3.30
$ 6.60
Diluted earnings per common share
$ 0.96
$ 1.00
$ 3.28
$ 6.55
ANALOG DEVICES, INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(thousands, except per share amounts)
Nov. 2, 2024
Oct. 28, 2023
ASSETS
Current Assets
Cash and cash equivalents
$ 1,991,342
$ 958,061
Short-term investments
371,822
—
Accounts receivable
1,336,331
1,469,734
Inventories
1,447,687
1,642,214
Prepaid expenses and other current assets
337,472
314,013
Total current assets
5,484,654
4,384,022
Other Assets
Net property, plant and equipment
3,415,550
3,219,157
Goodwill
26,909,775
26,913,134
Intangible assets, net
9,585,464
11,311,957
Deferred tax assets
2,083,752
2,223,272
Other assets
749,082
742,936
Total non-current assets
42,743,623
44,410,456
TOTAL ASSETS
$ 48,228,277
$ 48,794,478
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accounts payable
$ 487,457
$ 493,041
Income taxes payable
447,379
309,046
Debt, current
399,636
499,052
Commercial paper notes
547,738
547,224
Accrued liabilities
1,106,070
1,352,608
Total current liabilities
2,988,280
3,200,971
Non-current Liabilities
Long-term debt
6,634,313
5,902,457
Deferred income taxes
2,624,392
3,127,852
Income taxes payable
260,486
417,076
Other non-current liabilities
544,489
581,000
Total non-current liabilities
10,063,680
10,028,385
Shareholders’ Equity
Preferred stock, $1.00 par value, 471,934 shares authorized, none outstanding
—
—
Common stock, $0.16 2/3 par value, 1,200,000,000 shares authorized, 496,296,854 shares outstanding (496,261,678 on October 28, 2023)
82,718
82,712
Capital in excess of par value
25,082,243
25,313,914
Retained earnings
10,196,612
10,356,798
Accumulated other comprehensive loss
(185,256)
(188,302)
Total shareholders’ equity
35,176,317
35,565,122
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
$ 48,228,277
$ 48,794,478
ANALOG DEVICES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
Three Months Ended
Twelve Months Ended
Nov. 2, 2024
Oct. 28, 2023
Nov. 2, 2024
Oct. 28, 2023
Cash flows from operating activities:
Net income
$ 478,072
$ 498,430
$ 1,635,273
$ 3,314,579
Adjustments to reconcile net income to net cash provided by operations:
Depreciation
97,241
82,919
362,771
334,704
Amortization of intangibles
423,220
453,198
1,741,545
1,958,399
Stock-based compensation expense
70,448
72,710
262,710
299,823
Deferred income taxes
(97,997)
(21,553)
(367,563)
(452,946)
Other
(776)
(10,465)
23,050
8,665
Changes in operating assets and liabilities
80,609
112,055
194,743
(645,590)
Total adjustments
572,745
688,864
2,217,256
1,503,055
Net cash provided by operating activities
1,050,817
1,187,294
3,852,529
4,817,634
Percent of revenue
43 %
44 %
41 %
39 %
Cash flows from investing activities:
Purchases of short-term investments
—
—
(438,901)
—
Maturities of short-term investments
69,279
—
69,279
—
Additions to property, plant and equipment, net
(165,410)
(476,393)
(730,463)
(1,261,463)
Other
(15,483)
(2,668)
(4,773)
(4,922)
Net cash used for investing activities
(111,614)
(479,061)
(1,104,858)
(1,266,385)
Cash flows from financing activities:
Proceeds from debt
—
—
1,087,856
—
Early termination of debt
—
—
—
(65,688)
Debt repayments
(499,966)
—
(499,966)
—
Proceeds from commercial paper notes
2,474,948
2,640,615
10,184,439
5,287,124
Payments of commercial paper notes
(2,474,652)
(2,638,101)
(10,183,925)
(4,739,900)
Dividend payments to shareholders
(456,756)
(427,974)
(1,795,459)
(1,679,106)
Repurchase of common stock
(94,878)
(469,937)
(615,590)
(2,963,955)
Proceeds from employee stock plans
4,860
5,606
121,215
118,608
Other
(7,449)
(9,627)
(12,960)
(20,843)
Net cash used for financing activities
(1,053,893)
(899,418)
(1,714,390)
(4,063,760)
Net (decrease) increase in cash and cash equivalents
(114,690)
(191,185)
1,033,281
(512,511)
Cash and cash equivalents at beginning of period
2,106,032
1,149,246
$ 958,061
$ 1,470,572
Cash and cash equivalents at end of period
$ 1,991,342
$ 958,061
$ 1,991,342
$ 958,061
ANALOG DEVICES, INC.
REVENUE TRENDS BY END MARKET
(Unaudited)
(In thousands)
The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which our product will be incorporated. As data systems for capturing and tracking this data and our methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, we reclassify revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market.
Three Months Ended
Nov. 2, 2024
Oct. 28, 2023
Revenue
% of revenue*
Y/Y %
Revenue
% of revenue*
Industrial
$ 1,070,978
44 %
(21) %
$ 1,356,884
50 %
Automotive
716,964
29 %
(2) %
733,014
27 %
Communications
275,573
11 %
(18) %
336,238
12 %
Consumer
379,690
16 %
31 %
290,348
11 %
Total revenue
$ 2,443,205
100 %
(10) %
$ 2,716,484
100 %
Twelve Months Ended
Nov. 2, 2024
Oct. 28, 2023
Revenue
% of revenue*
Y/Y %
Revenue
% of revenue*
Industrial
$ 4,314,280
46 %
(35) %
$ 6,611,794
54 %
Automotive
2,827,439
30 %
(2) %
2,876,140
23 %
Communications
1,080,496
11 %
(33) %
1,606,426
13 %
Consumer
1,204,942
13 %
(1) %
1,211,179
10 %
Total revenue
$ 9,427,157
100 %
(23) %
$ 12,305,539
100 %
*The sum of the individual percentages may not equal the total due to rounding.
ANALOG DEVICES, INC.
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(Unaudited)
(In thousands, except per share amounts)
Three Months Ended
Twelve Months Ended
Nov. 2, 2024
Oct. 28, 2023
Nov. 2, 2024
Oct. 28, 2023
Gross margin
$ 1,416,128
$ 1,646,716
$ 5,381,343
$ 7,877,218
Gross margin percentage
58.0 %
60.6 %
57.1 %
64.0 %
Acquisition related expenses
243,667
259,925
1,022,488
1,047,309
Adjusted gross margin
$ 1,659,795
$ 1,906,641
$ 6,403,831
$ 8,924,527
Adjusted gross margin percentage
67.9 %
70.2 %
67.9 %
72.5 %
Operating expenses
$ 846,736
$ 1,012,301
$ 3,348,545
$ 4,054,106
Percent of revenue
34.7 %
37.3 %
35.5 %
32.9 %
Acquisition related expenses
(188,821)
(206,151)
(760,325)
(976,223)
Acquisition related transaction costs
—
—
—
(7,069)
Special charges, net
(2,859)
(114,035)
(37,258)
(160,710)
Adjusted operating expenses
$ 655,056
$ 692,115
$ 2,550,962
$ 2,910,104
Adjusted operating expenses percentage
26.8 %
25.5 %
27.1 %
23.6 %
Operating income
$ 569,392
$ 634,415
$ 2,032,798
$ 3,823,112
Operating margin
23.3 %
23.4 %
21.6 %
31.1 %
Acquisition related expenses
432,488
466,076
1,782,813
2,023,532
Acquisition related transaction costs
—
—
—
7,069
Special charges, net
2,859
114,035
37,258
160,710
Adjusted operating income
$ 1,004,739
$ 1,214,526
$ 3,852,869
$ 6,014,423
Adjusted operating margin
41.1 %
44.7 %
40.9 %
48.9 %
Nonoperating expense (income)
$ 53,064
$ 62,629
$ 255,458
$ 215,109
Acquisition related expenses
2,150
2,150
8,600
13,743
Adjusted nonoperating expense (income)
$ 55,214
$ 64,779
264,058
$ 228,852
Income before income taxes
$ 516,328
$ 571,786
$ 1,777,340
$ 3,608,003
Acquisition related expenses
430,338
463,926
1,774,213
2,009,789
Acquisition related transaction costs
—
—
—
7,069
Special charges, net
2,859
114,035
37,258
160,710
Adjusted income before income taxes
$ 949,525
$ 1,149,747
$ 3,588,811
$ 5,785,571
Provision for income taxes
$ 38,256
$ 73,356
$ 142,067
$ 293,424
Effective tax rate
7.4 %
12.8 %
8.0 %
8.1 %
Tax related items
76,702
70,503
265,697
388,093
Adjusted provision for income taxes
$ 114,958
$ 143,859
$ 407,764
$ 681,517
Adjusted tax rate
12.1 %
12.5 %
11.4 %
11.8 %
Diluted EPS
$ 0.96
$ 1.00
$ 3.28
$ 6.55
Acquisition related expenses
0.86
0.93
3.56
3.97
Acquisition related transaction costs
—
—
—
0.01
Special charges, net
0.01
0.23
0.07
0.32
Tax related items
(0.15)
(0.14)
(0.53)
(0.77)
Adjusted diluted EPS*
$ 1.67
$ 2.01
$ 6.38
$ 10.09
* The sum of the individual per share amounts may not equal the total due to rounding.
ANALOG DEVICES, INC.
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW
(Unaudited)
(In thousands)
Trailing
Twelve
Months
Three Months Ended
Nov. 2, 2024
Nov. 2, 2024
Aug. 3, 2024
May. 4, 2024
Feb. 3, 2024
Revenue
$ 9,427,157
$ 2,443,205
$ 2,312,209
$ 2,159,039
$ 2,512,704
Net cash provided by operating activities
$ 3,852,529
$ 1,050,817
$ 855,027
$ 807,853
$ 1,138,832
% of Revenue
41 %
43 %
37 %
37 %
45 %
Capital expenditures
$ (730,463)
$ (165,410)
$ (153,886)
$ (188,189)
$ (222,978)
Free cash flow
$ 3,122,066
$ 885,407
$ 701,141
$ 619,664
$ 915,854
% of Revenue
33 %
36 %
30 %
29 %
36 %
ANALOG DEVICES, INC.
RECONCILIATION OF PROJECTED GAAP TO NON-GAAP RESULTS
(Unaudited)
Three Months Ending February 1, 2025
Reported
Adjusted
Revenue
$2.35 Billion
$2.35 Billion
(+/- $100 Million)
(+/- $100 Million)
Operating margin
22.0 %
40.0 %(1)
(+/-130 bps)
(+/-100 bps)
Nonoperating expenses
~ $60 Million
~ $60 Million
Tax rate
12% – 14%
12% – 14% (2)
Earnings per share
$0.80
$1.53 (3)
(+/- $0.10)
(+/- $0.10)
(1) Includes $424 million of adjustments related to acquisition related expenses, as defined in the Non-GAAP Financial Information section of this press release.
(2) Includes $55 million of tax effects associated with the adjustments for acquisition related expenses noted above.
(3) Includes $0.73 of adjustments related to the net impact of acquisition related expenses and the tax effects on those items.
For more information, please contact:
Investor Contact:
Analog Devices, Inc.
Mr. Michael Lucarelli
Vice President, Investor Relations and FP&A
781-461-3282
investor.relations@analog.com
Media Contacts:
Analog Devices, Inc.
Ms. Ferda Millan
Global PR & External Communications
Ferda.Millan@analog.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/analog-devices-reports-fourth-quarter-and-fiscal-2024-financial-results-302315997.html
SOURCE Analog Devices, Inc.
You may like
Technology
HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple
Published
8 minutes agoon
July 21, 2026By
The article explains how sterile compounded medications are prepared to reduce the risk of contamination and support safe, customized treatments.
AZLE, Texas, July 21, 2026 /PRNewswire/ — What does sterile compounding mean for medication safety? HelloNation has published an article explaining how sterile compounding helps pharmacies prepare highly specialized medications while adhering to strict contamination-prevention procedures.
The article features insights from Laura Temple, Compounding Pharmacist Expert and Owner of Laura’s Pharmacy in Azle, Texas. It explains that sterile compounding is a specialized process for preparing medications in carefully controlled environments designed to reduce the risk of contamination. Sterile compounded medications are often used for injections, eye drops, IV medications, and other therapies that require the highest levels of cleanliness and precision.
The HelloNation article explains that sterile compounded medications differ from commercially manufactured drugs because they are prepared individually for a patient’s unique medical needs. Physicians may prescribe compounded prescriptions when a patient requires a customized dosage, a combination medication, or a treatment not commercially available. Because these medications often bypass the body’s natural defenses, medication safety depends on strict preparation standards throughout the compounding process.
The article describes how pharmacies that provide sterile compounding rely on cleanroom environments equipped with filtered-air systems, specialized equipment, and contamination-prevention protocols. Pharmacists and technicians follow detailed gowning, sterilization, and handwashing procedures before handling medication ingredients. These measures are designed to support medication safety by limiting exposure to bacteria, particles, and other contaminants.
According to the article, environmental monitoring also plays a critical role in sterile compounding. Temperature control, air quality testing, and routine equipment inspections help maintain consistent preparation standards. The article notes that sterile compounded medications may undergo additional quality assurance checks before being dispensed to patients. These procedures help support both treatment effectiveness and patient safety.
The HelloNation article also explains that pharmacies performing sterile compounding are expected to follow USP guidelines established for sterile preparation. These USP guidelines outline requirements for cleanroom pharmacy operations, environmental testing, employee training, and quality assurance practices. The article emphasizes that maintaining compliance with USP guidelines helps reinforce contamination prevention and consistent preparation standards for compounded prescriptions.
Patients seeking sterile compounded medications may also look for pharmacies that participate in accreditation programs or are overseen by state boards. The article explains that these programs review safety procedures, documentation practices, and facility standards to help maintain medication safety. Regular environmental monitoring and staff competency evaluations are also identified as important safeguards in sterile compounding operations.
The article further explains that communication between pharmacists, healthcare providers, and patients remains an important part of safe compounded prescriptions. Compounding pharmacists review prescriptions carefully, confirm dosing instructions, and evaluate ingredient compatibility before preparation begins. This collaborative approach supports medication safety by reducing the risk of errors and ensuring treatments meet individual patient needs.
The article concludes that sterile compounding continues to play an important role in healthcare, particularly for patients requiring customized therapies that are unavailable through traditional manufacturing channels. Whether preparing IV medications, injectable therapies, or other sterile compounded medications, pharmacies rely on contamination prevention procedures and strict preparation standards to support patient care. The article notes that understanding how sterile compounding works can help patients feel more informed about the safety measures involved in preparing specialized medications.
What Sterile Compounding Means for Medication Safety features insights from Laura Temple, a compounding pharmacist expert at Laura’s Pharmacy in Azle, Texas, on HelloNation.
About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.
View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-article-highlights-sterile-compounding-and-medication-safety-with-insights-from-compounding-pharmacist-expert-laura-temple-302831275.html
SOURCE HelloNation
Technology
CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group
Published
8 minutes agoon
July 21, 2026By
Regulatory demands are increasing in volume, complexity, and speed, leaving many organizations reliant on fragmented, manual approaches that slow response times and increase risk. New insights from Info-Tech Research Group show that organizations need to adopt more structured and scalable approaches to keep pace with regulatory change. The firm’s recently published blueprint, Build a Regulatory IT Response Engine, provides frameworks, tools, and step-by-step guidance to help organizations translate regulatory requirements into actionable IT controls and prioritized initiatives.
ARLINGTON, Va., July 21, 2026 /PRNewswire/ — Growing regulatory pressure across jurisdictions is forcing organizations to rethink how they interpret, prioritize, and execute compliance requirements. Many IT teams continue to operate with inconsistent processes and limited coordination, resulting in delayed initiatives and increased exposure to financial and reputational risk. Info-Tech’s blueprint, Build a Regulatory IT Response Engine, introduces a coordinated and repeatable approach to help IT leaders operationalize compliance and improve execution outcomes.
Info-Tech’s findings indicate that while organizations recognize the need for faster and more consistent regulatory response, they continue to face barriers such as fragmented interpretation of requirements, weak prioritization, and limited scalability. AI-enabled tools can help streamline analysis and accelerate response planning, but without a coordinated approach grounded in governance and human oversight, those benefits are difficult to realize.
“Regulatory response is becoming too complex to manage through disconnected, manual processes,” says Ahmad Jowhar, senior research analyst at Info-Tech Research Group. “IT leaders need a repeatable way to interpret requirements, prioritize action, and use AI to accelerate planning without losing the governance and oversight needed to execute effectively.”
Key Challenges IT Leaders Face in Regulatory Response
Despite ongoing investments in compliance, organizations continue to face systemic challenges that hinder effective execution. Info-Tech’s blueprint highlights several areas where IT and compliance leaders struggle most:
Fragmented and manual processes that slow regulatory interpretation and response.Inconsistent application of regulatory requirements across teams and jurisdictions.Poor prioritization of IT initiatives, leading to missed deadlines and duplicated effort.Limited scalability to manage increasing regulatory volume and complexity.Misalignment between compliance activities and broader business priorities.
Info-Tech’s Framework for Building a Regulatory IT Response Engine
To address these challenges, Info-Tech recommends a structured, AI-enabled approach that improves consistency, speed, and scalability. The firm’s Build a Regulatory IT Response Engine blueprint outlines the following key priorities for IT leaders:
Define the regulatory landscape: Establish organizational context, governance structures, and a centralized inventory of applicable regulations.Translate requirements into IT controls: Use AI-enabled analysis and structured assessments to convert regulatory obligations into actionable controls.Prioritize IT initiatives: Align initiatives based on cost, effort, impact, and regulatory timelines to reduce execution risk.Build and communicate a roadmap: Develop a clear, resource-aligned roadmap to guide execution and stakeholder alignment.Establish a repeatable process: Continuously monitor, adapt, and refine regulatory response capabilities to maintain compliance over time.
Organizations that adopt this structured approach can move from reactive compliance efforts to a more proactive and scalable model that shortens response timelines, reduces manual effort, and strengthens execution.
The firm’s Build a Regulatory IT Response Engine blueprint includes practical tools such as a Regulation Inventory Tool, a Regulatory Response IT Action Plan Tool, a Communication Deck Template, and a Compliance Program Framework. By applying these resources, IT leaders can standardize regulatory responses, improve prioritization, and help ensure compliance initiatives are executed on time and in alignment with business priorities.
For exclusive and timely commentary from Info-Tech’s experts, including Ahmad Jowhar, and access to the complete Build a Regulatory IT Response Engine blueprint, please contact pr@infotech.com.
About Info-Tech Research Group
Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.
To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.
Media professionals can register for unrestricted access to research across IT, HR, and software and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.
For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cios-forced-to-rethink-manual-compliance-processes-as-regulatory-complexity-rises-says-info-tech-research-group-302831286.html
SOURCE Info-Tech Research Group
Technology
Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026
Published
8 minutes agoon
July 21, 2026By
LOS GATOS, Calif., July 21, 2026 /PRNewswire/ — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, announced today that it plans to release its second quarter 2026 financial results after the market closes on Tuesday, Aug. 4, 2026.
The company will host a live video Zoom webinar at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, Aug. 4, 2026, to discuss the results. The live webinar can be accessed through Atomera’s investor relations website at https://ir.atomera.com. A replay of the webcast will be available for 12 months. To pre-register for the webinar, use the following link.
https://atomera.zoom.us/webinar/register/WN_OJFbTWe1SIyV69LLdDadCw
About Atomera
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-to-announce-second-quarter-2026-financial-results-and-host-webinar-on-tuesday-august-4-2026-302830602.html
SOURCE Atomera Incorporated
HelloNation Article Highlights Sterile Compounding and Medication Safety With Insights From Compounding Pharmacist Expert Laura Temple
CIOs Forced to Rethink Manual Compliance Processes as Regulatory Complexity Rises, Says Info-Tech Research Group
Atomera to Announce Second Quarter 2026 Financial Results and Host Webinar on Tuesday, August 4, 2026
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days agoTimed with the Canton Fair, Connexion ShenZhen 2026 Unveils Major Fourth-Edition Upgrades as a Greater Bay Area Mega Sourcing Event
-
Coin Market5 days agoBitcoin outlook improves amid 6% weekly gain: Can BTC bulls push higher?
-
Technology4 days agoGlobal Times: China sends fresh signal on global AI cooperation at WAIC
-
Coin Market4 days agoThe British Virgin Islands are a top crypto hub no one ever talks about: Here’s why
-
Coin Market5 days agoTrump teleprompter operator made $100K betting on Kalshi markets tied to speeches: ABC
-
Technology5 days agoGrand Bargain Project Announces Procedural Change that Will Turn Congress into a Problem-Solving Institution Within Days
-
Technology5 days agoDrake Expands End-to-End Professional Services with Launch of Drake Audit Defense™
-
Technology5 days agoTexas Instruments board declares third quarter 2026 quarterly dividend
